Destiny Hinton

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

Research suggests the influence of STEM teachers on the STEM identities and attitudes of elementary school students extend to after-school STEM clubs.

St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.

SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.

Microcephaly is a rare neurodevelopmental condition in which a baby’s head is much smaller than expected because the brain did not develop properly or stopped developing during pregnancy. St. Jude researchers identified cells in the outer radial glia in the developing brain that play an important role in microcephaly.

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.

St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.

St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.

Now is a great time for kids to get vaccinated against HPV and protected against six different cancers.

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.